Literature DB >> 30807924

USP7: Structure, substrate specificity, and inhibition.

Alexandra Pozhidaeva1, Irina Bezsonova2.   

Abstract

Turnover of cellular proteins is regulated by Ubiquitin Proteasome System (UPS). Components of this pathway, including the proteasome, ubiquitinating enzymes and deubiquitinating enzymes, are highly specialized and tightly regulated. In this mini-review we focus on the de-ubiquitinating enzyme USP7, and summarize latest advances in understanding its structure, substrate specificity and relevance to human cancers. There is increasing interest in UPS components as targets for cancer therapy and here we also overview the recent progress in the development of small molecule inhibitors that target USP7.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; DUB inhibition; Deubiquitinating enzyme; USP7; Ubiquitin-proteasome pathway

Mesh:

Substances:

Year:  2019        PMID: 30807924      PMCID: PMC6481172          DOI: 10.1016/j.dnarep.2019.02.005

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  118 in total

1.  Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.

Authors:  Muyang Li; Delin Chen; Ariel Shiloh; Jianyuan Luo; Anatoly Y Nikolaev; Jun Qin; Wei Gu
Journal:  Nature       Date:  2002-03-31       Impact factor: 49.962

2.  A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7.

Authors:  Mary Canning; Chris Boutell; Jane Parkinson; Roger D Everett
Journal:  J Biol Chem       Date:  2004-07-06       Impact factor: 5.157

3.  A dynamic role of HAUSP in the p53-Mdm2 pathway.

Authors:  Muyang Li; Christopher L Brooks; Ning Kon; Wei Gu
Journal:  Mol Cell       Date:  2004-03-26       Impact factor: 17.970

4.  Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization.

Authors:  Vivian Saridakis; Yi Sheng; Feroz Sarkari; Melissa N Holowaty; Kathy Shire; Tin Nguyen; Rongguang G Zhang; Jack Liao; Weontae Lee; Aled M Edwards; Cheryl H Arrowsmith; Lori Frappier
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

5.  Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14.

Authors:  Min Hu; Pingwei Li; Ling Song; Philip D Jeffrey; Tatiana A Chenova; Keith D Wilkinson; Robert E Cohen; Yigong Shi
Journal:  EMBO J       Date:  2005-10-06       Impact factor: 11.598

6.  GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7.

Authors:  Jan A van der Knaap; B R Prashanth Kumar; Yuri M Moshkin; Karin Langenberg; Jeroen Krijgsveld; Albert J R Heck; François Karch; C Peter Verrijzer
Journal:  Mol Cell       Date:  2005-03-04       Impact factor: 17.970

7.  Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.

Authors:  Melissa N Holowaty; Yi Sheng; Tin Nguyen; Cheryl Arrowsmith; Lori Frappier
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

8.  Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.

Authors:  Melissa N Holowaty; Mahel Zeghouf; Hong Wu; Judy Tellam; Vicki Athanasopoulos; Jack Greenblatt; Lori Frappier
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

9.  Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.

Authors:  Min Hu; Pingwei Li; Muyang Li; Wenyu Li; Tingting Yao; Jia-Wei Wu; Wei Gu; Robert E Cohen; Yigong Shi
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

10.  Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.

Authors:  Min Hu; Lichuan Gu; Muyang Li; Philip D Jeffrey; Wei Gu; Yigong Shi
Journal:  PLoS Biol       Date:  2006-01-17       Impact factor: 8.029

View more
  29 in total

1.  Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth.

Authors:  Xue Li; Lingmei Kong; Qihong Yang; Aizhu Duan; Xiaoman Ju; Bicheng Cai; Lin Chen; Tao An; Yan Li
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

2.  AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.

Authors:  Jingyue Jia; Bhawana Bissa; Lukas Brecht; Lee Allers; Seong Won Choi; Yuexi Gu; Mark Zbinden; Mark R Burge; Graham Timmins; Kenneth Hallows; Christian Behrends; Vojo Deretic
Journal:  Mol Cell       Date:  2020-01-28       Impact factor: 17.970

3.  The role of USP7 in the Shoc2-ERK1/2 signaling axis and Noonan-like syndrome with loose anagen hair.

Authors:  Patricia Wilson; Lina Abdelmoti; Rebecca Norcross; Eun Ryoung Jang; Malathy Palayam; Emilia Galperin
Journal:  J Cell Sci       Date:  2021-11-05       Impact factor: 5.285

4.  The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1.

Authors:  Ming Gao; Zijuan Qi; Min Deng; Hongyang Huang; Zhijie Xu; Guijie Guo; Jiajun Jing; Xiaofeng Huang; Ming Xu; Jake A Kloeber; Sijin Liu; Jinzhou Huang; Zhenkun Lou; Jinxiang Han
Journal:  Oncogene       Date:  2022-07-11       Impact factor: 8.756

5.  UBP12 and UBP13 deubiquitinases destabilize the CRY2 blue light receptor to regulate Arabidopsis growth.

Authors:  Louise N Lindbäck; Yuzhao Hu; Amanda Ackermann; Oliver Artz; Ullas V Pedmale
Journal:  Curr Biol       Date:  2022-06-13       Impact factor: 10.900

6.  Backbone and ILV side-chain NMR resonance assignments of the catalytic domain of human deubiquitinating enzyme USP7.

Authors:  Gabrielle Valles; Alexandra Pozhidaeva; Dmitry M Korzhnev; Irina Bezsonova
Journal:  Biomol NMR Assign       Date:  2022-05-10       Impact factor: 0.731

7.  USP7 Attenuates Endoplasmic Reticulum Stress and NF-κB Signaling to Modulate Chondrocyte Proliferation, Apoptosis, and Inflammatory Response under Inflammation.

Authors:  Xiaofei Dong; Chang Yang; Yao Luo; Wei Dong; Xiaoxiao Xu; Yanru Wu; Jiawei Wang
Journal:  Oxid Med Cell Longev       Date:  2022-04-06       Impact factor: 6.543

Review 8.  Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy.

Authors:  Xiao-Xin Sun; Yanping Li; Rosalie C Sears; Mu-Shui Dai
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

Review 9.  Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.

Authors:  Yanfeng Wang; Feng Wang
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

Review 10.  Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential.

Authors:  Jun-Nan Guo; Bai-Rong Xia; Shen-Hui Deng; Chang Yang; Ya-Nan Pi; Bin-Bin Cui; Wei-Lin Jin
Journal:  Front Cell Dev Biol       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.